Simplifying Global Compliance
Generic Drugmakers Will Benefit From China’s Low-Cost Drug List
Washington Drug Letter
Chinese authorities are gearing up to keep the cost of certain drugs sold in the country down via publication of a “low-cost” drug list expected to expand access to generics.
To View This Article:
Buy This Article Now
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing